A major outlet publishes a conflict-of-interest investigation into the FDA nominee's psychedelic ties before his confirmation resolves.

The person nominated to lead the FDA (the US drug regulator) has vocal, public connections to the psychedelic therapy world — including ties to podcaster Joe Rogan's media universe. The prediction is that a major news organization will publish an investigation into potential conflicts of interest before his confirmation process wraps up. When a regulator has financial or promotional ties to the very industry they'd oversee, it's a serious public accountability question.

A Rogan-backed psychedelic architect running FDA is irresistible copy. The story forces public moderation, not acceleration. Scrutiny is the predictable press response.